CSP Inc. 10-Q Filing Summary
Business Context and Reporting Period
This is a quarterly report (Form 10-Q) for CSP Inc., a Massachusetts corporation, for the three-month period ended December 1, 1995. The company operates through three primary divisions: Embedded Computing, Scanalytics (bio-instrumentation), and Vision Systems. As of January 4, 1996, there were 2,666,020 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 FY1996 (Ended Dec 1, 1995) | Q1 FY1995 (Ended Nov 25, 1994) |
|---|---|---|
| Sales | $4,370,000 | $4,620,000 |
| Net Income | $218,000 | ($432,000) Loss |
| Operating Income | $188,000 | ($685,000) Loss |
| EPS (Primary) | $0.08 | ($0.15) |
| Cash & Equivalents | $13,326,000 | $11,069,000 |
| Working Capital | $23,081,000 | $22,862,000 |
| Cost of Sales Margin | 40% | 48% |
| Net Cash from Operations | $913,000 | $1,300,000 |
The company reported no long-term debt on the balance sheet. Total assets were $29,709,000, with shareholders' equity totaling $25,899,000.
Material Changes vs. Prior Period
- Profitability Turnaround: The company shifted from a net loss of $432,000 to a net income of $218,000, a 150.5% improvement. This was driven by a $1.123 million reduction in total costs and expenses.
- Revenue Mix Shift: Sales declined 5.4% year-over-year. However, the product mix shifted significantly. Embedded Computing sales (75% of total) grew, driven by the Supercard family (70% of total sales vs. 28% prior year). Conversely, Vision Systems sales collapsed to 1% of total revenue from 45% in the prior year due to the completion of a major UPS contract.
- Cost Efficiency: Cost of sales as a percentage of revenue dropped from 48% to 40%, attributed to the shift away from low-margin machine code readers toward higher-margin embedded and bio-instrumentation products.
- Restructuring: The prior year included $409,000 in restructuring charges (severance and facility closure) which were absent in the current period.
Outlook, Risks, and Management Commentary
- Liquidity: Management states that current and foreseeable needs can be met through working capital and investments. The company maintains a conservative investment strategy with short-term liquid positions to avoid borrowing.
- Inventory Build: Inventory increased by $193,000, primarily due to purchasing long-lead-time items in anticipation of second-quarter sales.
- Stock Repurchase: The Board authorized an additional repurchase of up to 150,000 shares on September 28, 1995. The company repurchased 253,000 shares (cost) during the quarter.
- Risks: Management notes that while inflation had no significant impact in the current period, future inflation could materially and adversely affect the business. The company also faces risks related to the concentration of sales in specific product lines (Supercard) and the loss of large one-time contracts (UPS).
Investor Verification Checklist
- Verify the sustainability of the 40% cost of sales margin given the shift away from the high-volume UPS contract.
- Confirm the status of the "long-lead-time" inventory buildup and whether it aligns with actual Q2 demand forecasts.
- Review the specific terms and remaining authorization for the stock repurchase program.
- Assess the growth trajectory of the Scanalytics division (Cellscan product line) as a counterbalance to the decline in Vision Systems.
- Check for any new engineering and development expenses announced in October 1995 that may impact future quarters.